Abstract
Beta cell mass and function are decreased to varying degrees in diabetes. Islet cell replacement or regenerative therapy may offer great therapeutic promise to people with diabetes. In addition to primary pancreatic β cells, recent studies on regeneration of functional insulin producing cells (IPCs) revealed that several alternative cell sources, including embryonic stem cells, induced pluripotent stem cells and adult stem cells, can generate IPCs by differentiation, reprogramming, and trans-differentiation. In this review, we discuss stem cells as a potential alternative cell source for the treatment of diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Scully T. Diabetes in numbers. Nature, 2012, 485: S2–S3
van Belle T L, Coppieters K T, von Herrath M G. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev, 2011, 91: 79–118
Luan B, Zhao J, Wu H, et al. Deficiency of a beta-arrestin-2 signal complex contributes to insulin resistance. Nature, 2009, 457: 1146–1149
Nathan D M, Cleary P A, Backlund J Y, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med, 2005, 353: 2643–2653
Berney T, Johnson P R. Donor pancreata: evolving approaches to organ allocation for whole pancreas versus islet transplantation. Transplantation, 2010, 90: 238–243
Fridell J A, Rogers J, Stratta R J. The pancreas allograft donor: current status, controversies, and challenges for the future. Clin Transplant, 2010, 24: 433–449
Vardanyan M, Parkin E, Gruessner C, et al. Pancreas vs. islet transplantation: a call on the future. Curr Opin Organ Transplant, 2010, 15: 124–130
Shapiro A M, Lakey J R, Ryan E A, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med, 2000, 343: 230–238
Bonner-Weir S, Baxter L A, Schuppin G T, et al. A second pathway for regeneration of adult exocrine and endocrine pancreas. A possible recapitulation of embryonic development. Diabetes, 1993, 42: 1715–1720
Wang R N, Kloppel G, Bouwens L. Duct-to islet-cell differentiation and islet growth in the pancreas of duct-ligated adult rats. Diabetologia, 1995, 38: 1405–1411
Xu X, D’Hoker J, Stange G, et al. Beta cells can be generated from endogenous progenitors in injured adult mouse pancreas. Cell, 2008, 132: 197–207
Inada A, Nienaber C, Katsuta H, et al. Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birth. Proc Natl Acad Sci USA, 2008, 105: 19915–19919
Furuyama K, Kawaguchi Y, Akiyama H, et al. Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet, 2011, 43: 34–41
Bonner-Weir S, Li W C, Ouziel-Yahalom L, et al. Beta-cell growth and regeneration: replication is only part of the story. Diabetes, 2010, 59: 2340–2348
Brennand K, Huangfu D, Melton D. All beta cells contribute equally to islet growth and maintenance. PLoS Biol, 2007, 5: e163
Huising M O, van der Meulen T, Vaughan J M, et al. CRFR1 is expressed on pancreatic beta cells, promotes beta cell proliferation, and potentiates insulin secretion in a glucose-dependent manner. Proc Natl Acad Sci USA, 2010, 107: 912–917
Smukler S R, Arntfield M E, Razavi R, et al. The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell, 2011, 8: 281–293
Baeyens L, De Breuck S, Lardon J, et al. In vitro generation of insulin-producing beta cells from adult exocrine pancreatic cells. Diabetologia, 2005, 48: 49–57
Zhou Q, Brown J, Kanarek A, et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature, 2008, 455: 627–632
Mfopou J K, Chen B, Sui L, et al. Recent advances and prospects in the differentiation of pancreatic cells from human embryonic stem cells. Diabetes, 2010, 59: 2094–2101
Brolen G K, Heins N, Edsbagge J, et al. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing beta-cell-like cells. Diabetes, 2005, 54: 2867–2874
Kahan B W, Jacobson L M, Hullett D A, et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes, 2003, 52: 2016–2024
D’Amour K A, Bang A G, Eliazer S, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat Biotechnol, 2006, 24: 1392–1401
Kroon E, Martinson L A, Kadoya K, et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol, 2008, 26: 443–452
Chen S, Borowiak M, Fox J L, et al. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Nat Chem Biol, 2009, 5: 258–265
Bar-Nur O, Russ H A, Efrat S, et al. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell, 2011, 9: 17–23
Stadtfeld M, Nagaya M, Utikal J, et al. Induced pluripotent stem cells generated without viral integration. Science, 2008, 322: 945–949
Golestaneh N, Kokkinaki M, Pant D, et al. Pluripotent stem cells derived from adult human testes. Stem Cells Dev, 2009, 18: 1115–1126
Pileggi A. Mesenchymal stem cells for the treatment of diabetes. Diabetes, 2012, 61: 1355–1356
Rf M. Utility of mesenchymal stem cell therapy in type 1 diabetes. Stem Cells Cancer Stem Cells, 2012, 6: 197–203
Urban V S, Kiss J, Kovacs J, et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells, 2008, 26: 244–253
Ding Y, Xu D, Feng G, et al. Mesenchymal stem cells prevent the rejection of fully allogenic islet grafts by the immunosuppressive activity of matrix metalloproteinase-2 and -9. Diabetes, 2009, 58: 1797–1806
Kim S J, Choi Y S, Ko E S, et al. Glucose-stimulated insulin secretion of various mesenchymal stem cells after insulin-producing cell differentiation. J Biosci Bioeng, 2012, 113: 771–777
Ho J H, Tseng T C, Ma W H, et al. Multiple intravenous transplantations of mesenchymal stem cells effectively restore long-term blood glucose homeostasis by hepatic engraftment and beta-cell differentiation in streptozocin-induced diabetic mice. Cell Transplant, 2012, 21: 997–1009
Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol, 2003, 21: 763–770
Zaret K S, Grompe M. Generation and regeneration of cells of the liver and pancreas. Science, 2008, 322: 1490–1494
Ber I, Shternhall K, Perl S, et al. Functional, persistent, and extended liver to pancreas transdifferentiation. J Biol Chem, 2003, 278: 31950–31957
Yechoor V, Liu V, Espiritu C, et al. Neurogenin3 is sufficient for transdetermination of hepatic progenitor cells into neo-islets in vivo but not transdifferentiation of hepatocytes. Dev Cell, 2009, 16: 358–373
Yang L J. Liver stem cell-derived beta-cell surrogates for treatment of type 1 diabetes. Autoimmun Rev, 2006, 5: 409–413
Tang D Q, Wang Q, Burkhardt B R, et al. In vitro generation of functional insulin-producing cells from human bone marrow-derived stem cells, but long-term culture running risk of malignant transformation. Am J Stem Cells, 2012, 1: 114–127
Vajdic C M, van Leeuwen M T. Cancer incidence and risk factors after solid organ transplantation. Int J Cancer, 2009, 125: 1747–1754
Halban P A, German M S, Kahn S E, et al. Current status of islet cell replacement and regeneration therapy. J Clin Endocrinol Metab, 2010, 95: 1034–1043
Alipio Z, Liao W, Roemer E J, et al. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci USA, 2010, 107: 13426–13431
Cardinale V, Wang Y, Carpino G, et al. The biliary tree—a reservoir of multipotent stem cells. Nat Rev Gastroenterol Hepatol, 2012, 9: 231–240
Liu J, Liu Y, Wang H, et al. Direct differentiation of hepatic stem-like WB cells into insulin-producing cells using small molecules. Sci Rep, 2013, 3: 1185
Author information
Authors and Affiliations
Corresponding authors
Additional information
Contributed equally to this work
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Liu, X., Wang, Y., Li, Y. et al. Research status and prospect of stem cells in the treatment of diabetes mellitus. Sci. China Life Sci. 56, 306–312 (2013). https://doi.org/10.1007/s11427-013-4469-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-013-4469-1